Pioneering Test & Treat Diagnostics
Chlamydia, MRSA DNA testing analysis from Atlas Genetics
Investors Chlamydia DNA genetic testing analysis from Atlas Genetics


Atlas has raised more than £21 million in Series A and Series B finance. Investors include Consort Medical plc, Novartis Venture Funds, J&J Development Corp, Life Science Partners (LSP), BB Biotech Ventures, YFM Equity Partners and private investors.

Public Grants

Atlas has been awarded grant funding from the South West Regional Development Agency (SWRDA) and the United States Institutes of Health. We are currently working on a £1.6m grant funded project with The Technology Strategy Board, in partnership with Public Health England (formerly the HPA).